Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boram Bio is a South Korean biotechnology affiliate of the broader Boram Group. The company specializes in developing high-value-added products by applying biotechnology to agricultural and fishery raw materials—primarily focusing on health functional foods, cosmetic ingredients, and natural pharmaceutical-grade substances. It has developed patented materials for cognitive enhancement/dementia prevention ("beef") and joint function ("antisperil"), with ongoing R&D to commercialize these as natural medicines. The company is also expanding into smart farming clusters for novel plant varieties such as antisperil perilla seeds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boram.